AI Article Synopsis
- The study assesses the awareness of radiation safety among nursing staff at a major hospital, highlighting the necessity for better education on radiation exposure due to their potential involvement in radiological emergencies.
- Out of 200 nurses surveyed across 9 departments, 147 completed a questionnaire, resulting in an average score of only 40%, demonstrating a significant knowledge gap in radiation safety.
- 85% of nurses expressed the need for additional radiation safety training, suggesting the implementation of department-specific materials and the establishment of mandatory training courses for nurses working with radiation.
Article Abstract
Although the exposure to nursing staff is generally lower than the allowable radiation worker dose limits, awareness and overcoming fears of radiation exposure is essential in order to perform routine activities in certain departments. Furthermore, the nursing staff, whether they are defined as radiation workers or not, must be able to respond to any radiological emergencies and provide care to any patient affected by radiation. This study aims to gauge the awareness of radiation safety among the nursing staff at a major hospital in different departments and recommend if further radiation safety training is required. A prospective multiple choice questionnaire was distributed to 200 nurses in 9 different departments. The questionnaire tested knowledge that would be taught at a basic radiation safety course. 147 nurses (74%) completed the survey with the average score of 40%. Furthermore, 85% of nurses surveyed felt there was a need for radiation safety training in their respective departments to assist with day to day work in the department. An increase in radiation safety materials that are specific to each department is recommended to assist with daily work involving radiation. Moreover, nursing staff that interact with radiation on a regular basis should undertake radiation safety courses before beginning employment and regular refresher courses should be made available thereafter.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1088/0952-4746/36/1/178 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy of Neoadjuvant Radiotherapy After Chemotherapy and the Optimal Interval from Radiotherapy to Surgery for Borderline Resectable and Resectable Pancreatic Cancer.
Ann Surg Oncol
January 2025
Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Background: Benefits of neoadjuvant treatment for pancreatic cancer with major vessel invasion has been demonstrated through randomized controlled trials; however, the optimal neoadjuvant treatment strategy remains controversial, especially for radiotherapy. Therefore, we aimed to evaluate the efficacy and safety of neoadjuvant radiotherapy followed by chemotherapy and the optimal time interval to undergo surgery after radiotherapy in (borderline) resectable pancreatic cancer.
Methods: Between 2013 and 2022, patients with (borderline) resectable pancreatic cancer with vessel contact who received 5-fluorouracil with leucovorin, oxaliplatin, and irinotecan or gemcitabine and nanoparticle albumin-bound paclitaxel as initial treatment following surgery were included.
Breast Conservation Surgery for Breast Cancer in Men.
J Am Coll Surg
January 2025
The University of Texas Medical Branch at Galveston, Department of Surgery.
Background: Male breast cancer (MBC) is a rare disease, accounting for 1% of all breast cancers diagnosed in the United States. The rarity of MBC has limited the development of treatment algorithms specific to men. Thus, the standard of care has been mastectomy.
View Article and Find Full Text PDFImplementing Patient Protection Radiation Dose Alerts for Pediatric Cardiac Catheterization Examinations.
J Soc Cardiovasc Angiogr Interv
December 2024
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Background: Advancements in cardiac catheterization have improved survival for pediatric congenital heart disease patients, but the associated ionizing radiation risks necessitate ethical consideration.
Methods: This study presents an empirical model, developed from 3131 unique pediatric procedures, to establish alert levels based on a patient's lateral thickness of the thorax for various procedural categories during diagnostic or interventional cardiac catheterization. The model uses linear regression of logarithmic reference air kinetic energy released per unit mass (KERMA) and air KERMA area product, also referred to as dose area product, to set alert levels at the top 95% and 99% of patient data.
High‑intensity focused ultrasound thermal ablation boosts the efficacy of immune checkpoint inhibitors in advanced cancers with liver metastases: A single‑center retrospective cohort study.
Oncol Lett
March 2025
State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016, P.R. China.
High-intensity focused ultrasound thermal ablation (HIFU) is a novel non-invasive technique in the treatment of liver metastases (LIM) that allows focal destruction and is not affected by dose limits. This retrospective study aimed to explore the efficacy of HIFU in improving survival and the safety of the method in newly diagnosed patients with cancer with LIM who received first-line immune checkpoint inhibitor (ICI) therapy. Between January 2018 and December 2023, data from 438 newly diagnosed patients with cancer and LIM who were treated at Mianyang Central Hospital (Mianyang, China) were reviewed.
View Article and Find Full Text PDFA humanized anti-MSLN×4-1BB bispecific antibody exhibits potent antitumour activity through 4-1BB signaling activation and fc function without systemic toxicity.
J Transl Med
January 2025
Department of Medical Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, 230031, Anhui, China.
Background: Agonistic monoclonal antibodies targeting 4-1BB/CD137 have shown preclinical promise, but their clinical development has been limited by severe liver toxicity or limited efficacy. Therefore, a safe and efficient immunostimulatory molecule is urgently needed for cancer immunotherapy.
Methods: A novel anti-MSLN×4-1BB bispecific antibody (bsAb) was generated via antibody engineering, and its affinity and activity were detected via enzyme-linked immunosorbent assay (ELISA), flow cytometry, and T-cell activation and luciferase reporter assays.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!